Currently out of the existing stock ratings of Lisa Walter, 37 are a BUY (84.09%), 7 are a HOLD (15.91%).

Lisa Walter

Work Performance Price Targets & Ratings Chart

Analyst Lisa Walter, currently employed at RBC, carries an average stock price target met ratio of 26.39% that have a potential upside of 21.13% achieved within 108 days.

Lisa Walter’s has documented 89 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on EYPT, Eyepoint Pharmaceuticals at 18-Aug-2026.

Wall Street Analyst Lisa Walter

Analyst best performing recommendations are on EYPT (EYEPOINT PHARMACEUTICALS).
The best stock recommendation documented was for EYPT (EYEPOINT PHARMACEUTICALS) at 8/18/2026. The price target of $5 was fulfilled within 6 days with a profit of $0.47 (8.59%) receiving and performance score of 14.32.

Average potential price target upside

ADVM Adverum Biotechnologies APLS Apellis Pharmaceuticals EYPT Eyepoint Pharmaceuticals FDMT 4D Molecular Therapeutics  MGTX MeiraGTx Holdings PLC OCUL Ocular Therapeutix RYTM Rhythm Pharmaceuticals UTHR United Therapeutics VRDN Viridian Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Apr-2024

$5

$0.64 (14.68%)

9 months 24 days ago
(17-Nov-2025)

0/5 (0%)

$0.73 (17.10%)

Buy Since 01-Nov-2023

$5.5

$1.14 (26.15%)

$12

10 months 12 days ago
(29-Oct-2025)

1/7 (14.29%)

$1.27 (30.02%)

292

Hold Since 16-Apr-2025

$4

$-0.36 (-8.26%)

$5

10 months 13 days ago
(28-Oct-2025)

1/2 (50%)

$-0.26 (-6.10%)

168

Buy Since 18-Jul-2024

1 years 28 days ago
(13-Aug-2025)

2/3 (66.67%)

$30.52 (321.94%)

1046

Hold Since 19-Mar-2024

$4

$-0.36 (-8.26%)

$5

1 years 3 months 26 days ago
(15-May-2025)

4/6 (66.67%)

$1.95 (95.12%)

205

Show more analysts

Please expand the browser size to see the chart

Which stock is Lisa Walter most bullish on?

Potential upside of $189.39 has been obtained for UTHR (UNITED THERAPEUTICS)

Which stock is Lisa Walter most reserved on?

Potential downside of $0.42 has been obtained for EYPT (EYEPOINT PHARMACEUTICALS)

What Year was the first public recommendation made by Lisa Walter?

On 2024

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?